Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet! ; volume:23 ; number:1 ; day:9 ; month:1 ; year:2019 ; pages:1-2 ; date:12.2019
Critical care ; 23, Heft 1 (9.1.2019), 1-2, 12.2019
- Creator
-
Honore, Patrick M.
Bels, David De
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
Spapen, Herbert D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-018-2297-1
- URN
-
urn:nbn:de:101:1-2019021321312137968873
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Bels, David De
- Kugener, Luc
- Redant, Sebastien
- Attou, Rachid
- Gallerani, Andrea
- Spapen, Herbert D.
- SpringerLink (Online service)
Other Objects (12)
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?